IOL Chemicals plans ₹350 crore expansion to boost ibuprofen output
IOL Chemicals and Pharmaceuticals Ltd. plans to invest around ₹350 crore to expand ibuprofen manufacturing capacity at its Barnala, Punjab facility. It is setting up a new backward-integrated unit with 6,000 metric tonn annual capacity.
IOL Chemicals and Pharmaceuticals Ltd. plans to invest around ₹350 crore to expand ibuprofen manufacturing capacity at its existing Barnala, Punjab, facility, the company said Wednesday. The company is setting up a new fully backward-integrated unit with an annual capacity of 6,000 metric tonnes.